RAGE expression has also been linked to glioma-associated inflammation and angiogenesis, and its blockade can reduce tumor growth in preclinical studies17,18,30 Consistent with these studies, expression of esRAGE in patients is associated with decreased cancer risk as well as enhanced overall survival and prognosis.19 This evidence concerns the gene AGER and glioma.